Nick Lab: Current Research Projects and Grant Support

 

Viral-induced Adaptation of Neutrophil Response in ARDS

R01 HL090991

PI: Jerry A. Nick

Current Award Period: 7/24/09-5/31/10

Total Award Period: 7/24/07-5/31/11

Current Award Budget: $363,911

Total Award Budget: $1,455,644

Specific Aims:

  1. Prospectively test in ARDS patients the effect of neutrophil Interferon Stimulated Gene (ISG) upregulation on clinical parameters of disease severity and outcome.
  2. Prospectively test in neutrophils isolated from ARDS patients the effect of ISG upregulation on cellular response to pro-inflammatory stimuli and live bacteria.
  3. Prospectively test in ARDS patients the predictive value of ISG upregulation in whole blood as a biomarker of viral infection and a more severe clinical course.

ARRA Supplement to Viral-induced Adaptation of Neutrophil Response in ARDS

R01 HL090991-03S2

PI: Jerry A. Nick

Current Award Period: 7/01/09-6/30/10          

Total Award Period: 7/01/09-6/30/11

Current Award Budget: $141,602                   

Total Award Budget: $283,204

Specific Aims:

  1. Define a global gene expression profile in neutrophils from ARDS patients with high and low ISG expression.
  2. Test the ability of a directed gene expression profile of ISG upregulation to predict disease severity and outcome in ARDS.

ARRA Student Supplement to Viral-induced Adaptation of Neutrophil Response in ARDS

R01 HL090991-03S1

PI: Jerry A. Nick

Total Award Period: 7/01/09-6/30/11

Total Award Budget: $14,102

Specific Aim: Provide summer research experience for students and science educators.



Targeted Prevention or Treatment of Bacterial Biofilm Infections of Severe Burns and Wounds

Congressionally Directed Medical Research

Programs DR080371

PI: Jerry A. Nick

Current Award Period: 9/23/09-4/22/11          

Total Period: 9/23/09-4/22/11

Current Award Budget: $233,618                   

Total Budget: $233,618

Specific Aims:

  1. Test the capacity of N2 peptide, with and without azithromycin, to prevent post-burn P. aeruginosa wound infection.
  2. Test the capacity of N2 peptide with and without azithromycin to treat established P. aeruginosa wound infection, or to augment standard antibiotic treatment.


Prevention and Disruption of Pseudomonas aeruginosa biofilms

NJC CF Award

Max and Yetta Karasik Foundation for CF Research

PI: Jerry A. Nick

Current Award Period: 10/1/09-9/30/10          

Total Award Period: 10/1/02-9/30/10

Current Award Budget: $42,375                    

Total Award Budget: $246,618

Specific Aims:

  1. Develop a method to directly visualize the creation of P. aeruginosa biofilms via incorporation of polymers of F-actin and DNA.
  2. Test the capacity of treatments that depolymerize F-actin and DNA to disrupt P. aeruginosa biofilm from CF strains early and late in infection.
  3. Test the capacity of disruption of P. aeruginosa biofilm to facilitate antibiotic killing of the infection.

Colorado Bioscience Discovery Evaluation Grant Program

A Novel Compound For Pseudomonas Biofilm Disruption

PI: Jerry A. Nick

Award Period: 3/1/011-6/1/12

Current Budget: $79,800

Specific Aims:

  1. Synthesis of unique candidate molecules,
  2. Test in vitro the capacity of candidate molecules to disrupt medically relevant PA biofilms,
  3. Test in vivo the efficacy of candidate molecules to enhance antibiotic therapy of PA infection in a murine thermal injury model.


Cystic Fibrosis Foundation Care Center Award

CF Foundation

PI: Jerry A. Nick

Current Award Period: 7/1/10-6/30/11         

Total Award Period: 7/1/05-6/30/11

Current Award Budget: $84,000                  

Total Award Budget: $372,500

Specific Aim: Registry of CF patients served by the Adult CF Program


Cystic Fibrosis Foundation Translational Therapeutic Development Center Award

CF Foundation

Co-Investigator: Jerry A. Nick          

Current Award Period: 1/1/10-12/31/10          

Total Award Period: 11/1/03-12/31/10

Current NJC subcontract: $86,000                 

Total Award Budget: $607,403

Specific Aim: Support for clinical trials


Multi-center Trial to Validate Protein Biomarkers of a Pulmonary Exacerbation in CF

CFF

Local Site PI: Jerry A. Nick

Award Period: 2/1/08-present

Current Budget: $45,000

Specific Aims:

  1. To develop a CF lung injury biomarker panel that quickly demonstrates a response to treatment by determining changes in candidate protein biomarkers in blood before and after intravenous antibiotic treatment for an acute pulmonary exacerbation.
  2. To determine whether these candidate protein biomarkers in blood also predict a subsequent decline in lung function by collecting these specimens at a time of clinical stability in the same cohort as specific aim #1 (“return to baseline” samples) and annually over two subsequent years.
  3. To submit high-quality plasma samples, collected under strict industry-accepted SOPs from a large cohort of well-characterized CF persons, to the CFFT Sample Bank which can be made available to other investigators interested in CF biomarker research. 

 

Harry Schwachman Clinical Investigator Award

CFF

PI: R.L. Young, Sponsor: Jerry A. Nick

Award Period: 7/08-6/11

Current Budget: $100,000

Specific Aims: This three-year award provides the opportunity for clinically-trained physicians to develop into independent biomedical research investigators who are actively involved in CF-related areas.


 

Expanded Access Trial of Aztreonam for Inhalation

Gilead

Local Site PI: Jerry A. Nick

Award Period: 5/01/09-present

Current Budget: $10,000

Specific Aim: A Phase IV trial of inhaled aztreonam therapy in adults with Cystic Fibrosis.


Testing Redox Regulation as Anti-inflammatory Therapy in Cystic Fibrosis Lung Disease

KL2 Mentored Career Development Award (NIH)

PI: D.P. Nichols, Co-mentor: Jerry A. Nick  

Award Period: 9/10-8/13

Current Budget: $140,000

Specific Aims: This three-year award provides the opportunity for early stage physician scientist to develop into independent biomedical research investigators.

Faculty by Research

The discoveries made in the laboratories at National Jewish Health have a profound impact on the understanding and treatment of human disease.

Browse our Faculty by Area of Research.

Events

MAY
01
New York AIR Society
5/1/2014 7:00:00 PM
MAY
17
Cocktails with Class
5/17/2014 6:00:00 PM